Related Experiment Video
Updated: Aug 10, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
Published on: March 29, 2024
Regulating Neutrophil PAD4/NOX-Dependent Cerebrovasular Thromboinflammation
Junaid Ansari1, Shantel A Vital2, Shreya Yadav3
1Department of Neurology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, 71130, USA.
Targeting Peptidyl Arginine Deiminase 4 (PAD4) and NADPH oxidase (NOX) inhibits neutrophil extracellular trap (NET) production. This approach reduces pathological NETs and cerebral thrombosis, offering a potential strategy for preventing stroke in conditions like Sickle Cell Disease.
Area of Science:
- Hematology and Immunology
- Neuroscience and Neurology
- Vascular Biology
Background:
- Neutrophil extracellular trap (NET) production is linked to thromboinflammation in Sickle Cell Disease (SCD), increasing ischemic stroke risk.
- Peptidyl Arginine Deiminase 4 (PAD4) and NADPH oxidase (NOX)-dependent reactive oxygen species (ROS) are critical for NET formation and neutrophil function.
- The precise role of NOX-dependent ROS and NETs in SCD-related cerebral microvascular thrombosis remains unclear.
Purpose of the Study:
- To investigate the role of NOX-dependent ROS and NETs in accelerated cerebral microvascular thrombosis in SCD.
- To evaluate the therapeutic potential of targeting PAD4 and NOX in mitigating thromboinflammation and stroke risk.
Main Methods:
- In vitro studies utilized neutrophils from healthy volunteers and SCD patients to assess the effects of targeting PAD4 and NOX on NET production.
- In vivo studies employed a photoactivation thrombosis model in mice (C57BL/6 and sickle transgenic mice) to examine the impact of PAD4 and NOX inhibition on cerebral microcirculation.
- Real-time fluorescence intravital microscopy was used to assess blood flow dynamics in cerebral microvessels.
Main Results:
- Targeting PAD4 and NOX significantly inhibited ionomycin-dependent H3cit+ neutrophils in human neutrophils.
- In vivo inhibition of PAD4 and NOX prolonged blood flow cessation in cerebral arterioles and venules in mice.
- These findings were replicated in a clinical model of accelerated thromboinflammation, showing attenuation of H3cit+ neutrophil production in SCD patient neutrophils.
Conclusions:
- PAD4 and NOX play a significant role in neutrophil-mediated thromboinflammation.
- Targeting PAD4 and NOX effectively limits pathological H3cit+ neutrophils, suggesting a mechanism for attenuating cerebral thrombosis.
- This study establishes a viable preclinical model for preventing and managing thromboinflammatory complications like ischemic stroke.
Related Concept Videos
Nitric Oxide Signaling Pathway
Inflammation
Regulation of Angiogenesis and Blood Supply
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

